Corpay to invest $1.1B in BILL as part of take-private deal
Corpay (CPAY) will invest $1.1B in BILL (BILL) as part of a take-private deal with TPG, valuing BILL at $6.0B. Corpay will acquire a third of BILL's equity with an option to buy the rest. The deal, at $63.25 per share, is expected to close in early 2027 and is projected to be accretive to Corpay's earnings in 2027, according to Corpay.
How this was made
The 30-second read
Why it matters
This is a definitive M&A announcement with a stated per-share price and valuation, plus a large committed investment ($1.1B) and a clear closing window (H1 2027).
Market read
Traders can model deal-spread dynamics using the offer price ($63.25), valuation ($6.0B), and definitive agreement status, while monitoring approval risk into H1 2027.
What to watch
The article highlights Corpay’s option to increase stake (to 100% by 2030) and expected accretion, but does not quantify deal financing terms or integration assumptions, which can drive revisions to deal economics.
Background
Corpay and TPG are taking BILL private; Corpay will initially buy about one-third equity and has an option to acquire the remainder.
Ticker impact
Corpay signed a definitive deal to invest $1.1B in BILL as part of a take-private transaction alongside TPG, with closing targeted for H1 2027.
Likely supportive bias as the market prices in deal economics and accretion claims, tempered by deal-completion and regulatory approval risk.
The article discloses a definitive agreement, specific investment size ($1.1B), and expected accretion to cash EPS in 2027, which are direct drivers for valuation and risk.
BILL agreed to be taken private at $63.25 per share, with Corpay committing $1.1B and an option for Corpay to buy up to 100%.
Likely upward pressure toward the offer price as deal certainty improves, with volatility around approvals and closing timing.
The article provides the per-share offer price ($63.25), total valuation ($6.0B), and definitive agreement status, which typically dominate near-term pricing.
Market effects
Reinforces consolidation momentum in spend management and accounts payable software, potentially supporting deal appetite for adjacent payments infrastructure.
Primarily US-listed corporate finance and payments names; limited direct regional spillover beyond deal comps.
Cross-border payments and SMB finance themes may attract broader international M&A attention, though the catalyst is company-specific.
Counterpoint
Even with a definitive agreement, deal spreads can widen if regulatory scrutiny or shareholder opposition emerges, making near-term upside less linear than the headline offer price implies.
Key entities
- companyCorpay, Inc.
NYSE-listed payments/spend management company investing $1.1B in BILL as part of the take-private transaction.
- companyBILL
Spend management and accounts payable solutions provider being taken private at $63.25 per share.
- private_equityTPG
Co-sponsor of the take-private transaction alongside Corpay.
